跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
matrix metalloprotease 9
首页
药物
matrix metalloprotease 9
matrix metalloprotease 9
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
US 6890937 B2
申请人: PHARMACIA CORP
优先权: 2000
US
4 件公开
US 6750228 B1
申请人: PHARMACIA CORP
优先权: 2000
US
2 件公开
US 2002177588 A1
申请人: BARTA THOMAS E
优先权: 2001
US
2 件公开
Multicistronic constructs with siRNA to inhibit tumors
US 7893035 B2
申请人: UNIV ILLINOIS
优先权: 2007
US
3 件公开
Use of a matrix-metalloprotease inhibitor for the treatment of cancer
EP 1174129 A1
申请人: ZENNER HANS PETER PROF DR MED
优先权: 2000
EP
US
2 件公开
ADENO ASSOCIATED VIRUS (AAV) MEDIATED LYSYL OXIDASE GENE THERAPY FOR KERATOCONUS AND THE CONSTRUCTS THEREOF
EP 4728083 A1
申请人: NARAYANA NETHRALAYA FOUND
优先权: 2023
EP
WO
2 件公开
Plant extracts and dermatological uses thereof
US 2007122492 A1
申请人: BEHR STEPHEN
优先权: 2004
US
2 件公开
Extracts of durian fruit for use in skin care compositions
US 2007042064 A1
申请人: ACCESS BUSINESS GROUP INT LLC
优先权: 2005
US
2 件公开
alpha-amino-beta-sulfonyl hydroxamic acid compounds
US 6583299 B1
申请人: SEARLE & CO
优先权: 2000
US
Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same
US 2005260582 A1
申请人: KAI HIROFUMI
优先权: 2001
US
Drug for Inhibiting Production of Matrix Metalloprotease-9
US 2008119558 A1
申请人: JAPAN SCIENCE & TECH AGENCY
优先权: 2002
US
SLIMMING COSMETIC COMPOSITION COMPRISING A METALLOPROTEINASE INHIBITOR AS AN ACTIVE AGENT
EP 1722757 B1
申请人: CLARINS LAB
优先权: 2005
EP
第 1 / 2 页
上一页
下一页
药物
反馈